优化L-阿斯巴拉基因酶生产的基因来源:一个比较性审查
Vida Ebrahimi1, Atieh Hashemi2
1Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, No. 2660, Valiasr-Niayesh Junction, Vali-E-Asr Ave, Tehran, 19968-35113, Iran.
Current microbiology
|July 11, 2025
概括
本综述评估了用于癌症治疗和食品安全的L-阿斯巴拉基因酶基因来源. 应用驱动的基因选择优化了酶的性能,从而改善了治疗和食品生产的结果.
科学领域:
- 生物化学 生物化学
- 生物技术是生物技术.
- 酵素工程是什么? 酶工程是什么
背景情况:
- 通过耗尽L-asparagine,L-asparaginase对于治疗急性淋巴细胞白血病至关重要.
- 该酶还减少了高温加工的粉食品中的烯胺的形成,提高了食品安全.
- 酶的性能,稳定性,免疫性和生产可行性受到基因来源的显著影响.
研究的目的:
- 系统地审查和评估L-阿斯巴拉基因酶基因来源.
- 评估不同基因来源对特定应用的适用性,包括癌症治疗,食品安全和生物感知.
- 突出应用驱动基因采购的好处,以开发改进的L-asparaginase变体.
主要方法:
- 在主要的生物医学数据库中进行全面的文献搜索.
- 基于特定应用的标准,对L-阿斯巴拉金酶基因源进行系统评估.
- 对来自各种基因来源的酶特性进行比较分析.
主要成果:
- 确定了关键的L-阿斯巴拉基因酶基因来源及其特征.
- 基因源与酶有效性,稳定性和免疫性之间的相关性被证明.
- 突出特定的基因来源最佳用于治疗与食品工业应用.
结论:
- 应用驱动的基因采购对于优化L-asparaginase至关重要.
- 这种方法可以导致更安全,更有效和经济可行的酶变体.
- 提供了对酶设计和部署用于临床和工业用途的未来进步的见解.
更多相关视频
相关概念视频
01:22Bioreactor Controls-III
70
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
70
01:30Production of Pharmaceuticals
99
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
99